Table 3.
Therapeutic strategies used by cancer patients during the pandemic.
Cancer Type | Personalized Protocol | References |
---|---|---|
Breast cancer | Antiviral combination of darunavir/cobicistat in addition to tazobactam, piperacillin, levofloxacillin and hydroxychloroquine | [63] |
Lung cancer | Combination of Hydroxychloroquine + azithromycin + lopinavir/ritonavir | [64] |
Chronic lymphocytic leukemia | Hydroxychloroquine, Remdesivir, Lopinavir/Ritonavir, Tocilizumab, Intravenous immunoglobulin, Corticosteroids, Azithromycin, Convalescent Plasma | [65] |
Solid and hematological malignancies | Azithromycin + Hydroxychloroquine | [66] |
Multiple cancers | Azithromycin, Remdesivir, Tocilizumab, Hydroxychloroquine, Convalescent plasma, Systemic corticosteroids | [67] |
Pediatric cancers | Broad-spectrum antibiotics, Hydroxychloroquine, Lopinavir/Ritonavir, Oxygen support | [68] |